Study in Patients With COPD

Phase 2

Completed

• Conditions: COPD; Chronic Obstructive Pulmonary Disease

• Registration Number: NCT00215423
• Lead Sponsor: Dey

Brief Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug

Detailed Description

Not available

Study Timeline

• Primary Completion: 2003-12
• Study Completion: 2005-09
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-14
• Study First Posted: 2005-09-22
• Status Verified: 2008-08
• Last Update Submitted: 2010-11-10
• Last Update Posted: 2010-11-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• Diagnosis of COPD
• History of cigarette smoking

Exclusion Criteria

• Clinical diagnosis of asthma
• Significant pulmonary disease other than COPD
• Other significant major organ disease(s)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Measure of lung function

Secondary Outcome Measures

Name	Time	Method
Change in lung function, as well as vital signs
Physical Exam results, adverse event reporting, etc

Trial Locations

Locations (1)

Research Site; 🇺🇸 Medford, Oregon, United States